MycoMedica LIFE SCIENCES — 2353528
Application number
2353528
International Registration Number
1813333
Type(s)
Design
Category
Trademark
CIPO Status
APPROVED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2024-07-17
International Registration
2024-07-17
Registration Expiry Date
2034-07-17
Applicant
MycoMedica Life Sciences, PBC
50 S.E. Nelson Road
Shelton WA 98584
UNITED STATES OF AMERICA
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Trademark description
The mark consists of the term MYCOMEDICA over the term LIFE SCIENCES all next to a sun with rays made of circles of various shades of blue.
Index headings
- MYCOMEDICA LIFE SCIENCES
- MYCO MEDICA
Vienna information (Code & Description)
- 1.3.2
- Other representations of the sun
- A 1.3.15
- Sun with rays constituted by rectilinear lines, sheaves of lines or bands
- 24.17.1
- Punctuation marks
- A 24.17.2
- Dots
- 25.7.1
- Surfaces or backgrounds covered with repeated geometrical figures or designs
- A 25.7.7
- Surfaces or backgrounds covered with dots
- 26.1.1
- Circles
- A 26.1.3
- One circle or ellipse
- A 26.1.26
- Circles or ellipses with cutout areas
- 26.11.3
- More than two lines or two bands
- A 26.11.7
- Vertical lines or bands
- A 26.11.8
- Horizontal lines or bands
- A 26.11.9
- Oblique lines or bands
- A 26.11.10
- Straight lines or bands
- A 26.11.14
- Dotted lines or bands
- 29.1.4
- Blue
Colour claim
The color(s) blue is/are claimed as a feature of the mark. The mark consists of the term MYCOMEDICA over the term LIFE SCIENCES all next to a sun with rays made of circles of various shades of blue.
Services (Nice class & Statement)
- 42
- (1) Pharmaceutical and biologic therapeutic drug development for treatment of psychiatric diseases, drug and chemical addictions, mental health conditions, neurodegenerative diseases, and central nervous system diseases and disorders; clinical and non-clinical scientific research services for the development of pharmaceuticals for treatment of psychiatric diseases, drug and chemical addictions, mental health conditions, and neurodegenerative diseases, and central nervous system diseases and disorders.
Claims
- Priority Filing Date: February 15, 2024, Country or Office: UNITED STATES OF AMERICA, Application No. 98407119 in association with the same kind of services
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2024-07-17 | Registration | |
| International Registration | 2024-07-17 | 2034-07-17 | |
| Created | 2024-10-02 | ||
| Formalized | 2024-10-02 | ||
| Designation Notification - Madrid Protocol | 2024-10-03 | 2026-04-03 | |
| Agent Changed | 2024-10-23 | From/De: To/A: 12 | |
| Notification of Possible Opposition Sent | 2025-08-04 | ||
| Search Recorded | 2025-10-07 | ||
| Examiner's First Report | 2025-10-07 | 2026-04-07 | |
| Total Provisional Refusal | 2025-10-07 | 2026-04-07 | |
| Approved | 2026-04-21 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2026-04-21 | APPROVED BY PROGRAM EX200M1 | |
| Agent Changed | 2026-04-21 | Transferred From: 12 To: 59 |